Impact of time to testosterone rebound and comorbidity on the risk of cause-specific mortality in men with unfavorable-risk prostate cancer-Reference-Cited by-同舟云学术

Impact of time to testosterone rebound and comorbidity on the risk of cause-specific mortality in men with unfavorable-risk prostate cancer

Author:

McDuff Susan G.R.¹²^ORCID,Chen Ming-Hui³,Renshaw Andrew A.⁴^ORCID,Loffredo Marian J.²,Kantoff Philip W.⁵,D'Amico Anthony V.²

Affiliation:

1. Harvard Radiation Oncology Program, Brigham and Women's Hospital; Dana-Farber Cancer Institute; Boston Massachusetts

2. Department of Radiation Oncology, Brigham and Women's Hospital; Dana-Farber Cancer Institute; Boston Massachusetts

3. Department of Statistics; University of Connecticut; Storrs Connecticut

4. Department of Pathology; Baptist Hospital and Miami Cancer Institute; Miami Florida

5. Department of Medicine; Memorial Sloan Kettering Cancer Center; New York New York

Funder

National Institutes of Health

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference34 articles.

1. Androgen suppression and radiation vs radiation alone for prostate cancer;D'Amico;JAMA.,2008

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献